Taipei, Taiwan

Pei Kan

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Pei Kan: Innovator in Pharmaceutical Compositions

Introduction

Pei Kan is a prominent inventor based in Taipei, Taiwan, known for his significant contributions to the field of pharmaceutical compositions. With a total of 10 patents to his name, he has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Liposome compositions comprising weak acid drugs and uses thereof." This invention relates to a pharmaceutical composition that includes a weak acid drug, utilizing a bicarbonate salt to enhance the drug's incorporation into liposomes, thereby improving therapeutic efficacy. Additionally, he has developed a patent for a "Pharmaceutical composition of a weak acid drug and methods of administration," which focuses on a composition containing liposomes that encapsulate a weak acid drug with a short half-life. This innovation aims to treat pulmonary hypertension while reducing the frequency of dosing.

Career Highlights

Pei Kan has worked with notable companies such as Tlc Biopharmaceuticals, Inc. and Pharmosa Biopharm Inc., where he has applied his expertise in pharmaceutical development. His work has significantly impacted the industry, particularly in the formulation of effective drug delivery systems.

Collaborations

Throughout his career, Pei Kan has collaborated with talented individuals, including Yun-Long Tseng and Yi Fong Lin, who have contributed to his research and development efforts.

Conclusion

Pei Kan's innovative work in pharmaceutical compositions has paved the way for improved treatments in respiratory diseases and other medical conditions. His contributions continue to influence the field and enhance therapeutic outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…